Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
5
×
biotech
boston blog main
boston top stories
clinical trials
life sciences
national blog main
archive
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
medical
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
recalls
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alder biopharmaceutical
alexion pharmaceuticals
allergan
american academy of neurology
american society of clinical oncology (asco)
amgen
amyotrophic lateral sclerosis (als)
What
drug
5
×
potential
5
×
class
drugs
medication
meeting
migraine
recalled
acceptable
additional
ahead
alternative
ambien
american
annual
approval
arguments
asco
attendees
attention
autoimmune
bacteria
based
big
biotech
brand
camp’s
cancer
candidate
cash
chicago
city
clinical
combinations
comes
commercialized
community’s
companies
company
competitors
Language
unset
Current search:
fda
×
drug
×
potential
×
@slashgear.com
3 years ago
Diabetes drug metformin recalled yet again: Why that matters
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@slashgear.com
4 years ago
Popular migraine drug recalled over potentially serious bacteria risk
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More